Nasopharyngeal Neoplasms D009303

Related MeSH Hierarchy (6)

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Head and Neck Neoplasms » Otorhinolaryngologic Neoplasms » Pharyngeal Neoplasms » Nasopharyngeal Neoplasms

Diseases [C] » Stomatognathic Diseases [C07] » Pharyngeal Diseases » Nasopharyngeal Diseases » Nasopharyngeal Neoplasms

Diseases [C] » Stomatognathic Diseases [C07] » Pharyngeal Diseases » Pharyngeal Neoplasms » Nasopharyngeal Neoplasms

Diseases [C] » Otorhinolaryngologic Diseases [C09] » Otorhinolaryngologic Neoplasms » Pharyngeal Neoplasms » Nasopharyngeal Neoplasms

Diseases [C] » Otorhinolaryngologic Diseases [C09] » Pharyngeal Diseases » Nasopharyngeal Diseases » Nasopharyngeal Neoplasms

Diseases [C] » Otorhinolaryngologic Diseases [C09] » Pharyngeal Diseases » Pharyngeal Neoplasms » Nasopharyngeal Neoplasms

Description

Tumors or cancer of the NASOPHARYNX.   MeSH

Hierarchy View

Subtype Terms (1)

Nasopharyngeal Carcinoma
140 drugs (61 approved, 79 experimental)



Organization Involved with Phase 4 Indications (4)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.